{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T02:08:21Z","timestamp":1793153301446,"version":"4.5.0"},"reference-count":157,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.autrev.2025.103741","type":"journal-article","created":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T06:03:26Z","timestamp":1736057006000},"page":"103741","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Cerebral iron accumulation in multiple sclerosis: Pathophysiology and therapeutic implications"],"prefix":"10.1016","volume":"24","author":[{"given":"Geir","family":"Bj\u00f8rklund","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Hangan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Butnariu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard","family":"Gurgas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Peana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2025.103741_bb0005","author":"Multiple Sclerosis International Federation"},{"key":"10.1016\/j.autrev.2025.103741_bb0010","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/brain\/awac092","article-title":"Polygenic risk score association with multiple sclerosis susceptibility and phenotype in Europeans","volume":"146","author":"Shams","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2025.103741_bb0015","article-title":"Iron and neurodegeneration in multiple sclerosis","volume":"2011","author":"Khalil","year":"2011","journal-title":"Mult Scler Int"},{"key":"10.1016\/j.autrev.2025.103741_bb0020","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jinorgbio.2019.03.013","article-title":"The essential metals for humans: a brief overview","volume":"195","author":"Zoroddu","year":"2019","journal-title":"J Inorg Biochem"},{"key":"10.1016\/j.autrev.2025.103741_bb0025","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3389\/fnagi.2013.00034","article-title":"A delicate balance: iron metabolism and diseases of the brain","volume":"5","author":"Hare","year":"2013","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.autrev.2025.103741_bb0030","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.2174\/0929867330666230324154606","article-title":"Perspectives on iron deficiency as a cause of human disease in global public health","volume":"31","author":"Bjorklund","year":"2024","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.autrev.2025.103741_bb0035","doi-asserted-by":"crossref","first-page":"4233","DOI":"10.2174\/0109298673263003231228060800","article-title":"Iron-related biomarkers in the diagnosis and management of iron disorders","volume":"31","author":"Semenova","year":"2024","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.autrev.2025.103741_bb0040","doi-asserted-by":"crossref","DOI":"10.1177\/1759091420962681","article-title":"Iron metabolism in oligodendrocytes and astrocytes, implications for myelination and remyelination","volume":"12","author":"Cheli","year":"2020","journal-title":"ASN Neuro"},{"key":"10.1016\/j.autrev.2025.103741_bb0045","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/s41380-023-02399-z","article-title":"Iron imbalance in neurodegeneration","volume":"29","author":"Levi","year":"2024","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.autrev.2025.103741_bb0050","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1177\/107385840000600607","article-title":"Iron in the brain: an important contributor in normal and diseased states","volume":"6","author":"Pi\u00f1ero","year":"2000","journal-title":"Neuroscientist"},{"key":"10.1016\/j.autrev.2025.103741_bb0055","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S1474-4422(14)70117-6","article-title":"The role of iron in brain ageing and neurodegenerative disorders","volume":"13","author":"Ward","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.autrev.2025.103741_bb0060","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s41747-022-00279-9","article-title":"Iron deposition in multiple sclerosis: overall load or distribution alteration?","volume":"6","author":"Hamdy","year":"2022","journal-title":"Eur Radiol Exp"},{"key":"10.1016\/j.autrev.2025.103741_bb0065","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.nurt.2007.05.006","article-title":"Iron in chronic brain disorders: imaging and neurotherapeutic implications","volume":"4","author":"Stankiewicz","year":"2007","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.autrev.2025.103741_bb0070","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1523\/JNEUROSCI.2434-19.2020","article-title":"Longitudinal development of brain iron is linked to cognition in youth","volume":"40","author":"Larsen","year":"2020","journal-title":"J Neurosci"},{"key":"10.1016\/j.autrev.2025.103741_bb0075","first-page":"279","article-title":"Brain iron homeostasis","volume":"49","author":"Moos","year":"2002","journal-title":"Dan Med Bull"},{"key":"10.1016\/j.autrev.2025.103741_bb0080","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3389\/fnins.2019.00086","article-title":"Oxidative stress related to Iron metabolism in relapsing remitting multiple sclerosis patients with low disability","volume":"13","author":"Siotto","year":"2019","journal-title":"Front Neurosci"},{"key":"10.1016\/j.autrev.2025.103741_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2020.100867","article-title":"The roles of iron and HFE genotype in neurological diseases","volume":"75","author":"Kim","year":"2020","journal-title":"Mol Asp Med"},{"key":"10.1016\/j.autrev.2025.103741_bb0090","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/mdc3.13933","article-title":"Estimation of ambulation and survival in neurodegeneration with brain iron accumulation disorders","volume":"11","author":"Amini","year":"2024","journal-title":"Mov Disord Clin Pract"},{"issue":"Suppl. 1","key":"10.1016\/j.autrev.2025.103741_bb0095","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/j.parkreldis.2015.08.012","article-title":"Neurodegenerations with brain Iron accumulation","volume":"22","author":"Schneider","year":"2016","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.autrev.2025.103741_bb0100","doi-asserted-by":"crossref","unstructured":"C.E. Miley, & Forster, F. M. Paroxysmal signs and symptoms in multiple sclerosis. Neurology 24(5), 458\u2013461, in: P.F. Bladin (Ed.), Multiple sclerosis. Presenting symptomatology. Australian family physician, 1974, pp. 155\u2013163. https:\/\/doi.org\/10.1212\/wnl.24.5.458.","DOI":"10.1212\/WNL.24.5.458"},{"key":"10.1016\/j.autrev.2025.103741_bb0105","first-page":"26","article-title":"Health care costs of veterans with multiple sclerosis: implications for the rehabilitation of MS. VA multiple sclerosis rehabilitation study group","volume":"74","author":"Bourdette","year":"1993","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.autrev.2025.103741_bb0110","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1002\/acn3.50893","article-title":"Iron homeostasis, complement, and coagulation cascade as CSF signature of cortical lesions in early multiple sclerosis","volume":"6","author":"Magliozzi","year":"2019","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.autrev.2025.103741_bb0115","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41582-021-00581-x","article-title":"Mechanism-based criteria to improve therapeutic outcomes in progressive multiple sclerosis","volume":"18","author":"Yong","year":"2022","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.autrev.2025.103741_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.104934","article-title":"Iron in multiple sclerosis - neuropathology, immunology, and real-world considerations","volume":"78","author":"Zierfuss","year":"2023","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.autrev.2025.103741_bb0125","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jtemb.2014.12.012","article-title":"Neurodegenerative diseases and therapeutic strategies using iron chelators","volume":"31","author":"Ward","year":"2015","journal-title":"J Trace Elem Med Biol"},{"key":"10.1016\/j.autrev.2025.103741_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2023.122807","article-title":"MR myelin imaging in multiple sclerosis: a scoping review","volume":"455","author":"Khormi","year":"2023","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.autrev.2025.103741_bb0135","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.nicl.2017.11.003","article-title":"Iron-related gene variants and brain iron in multiple sclerosis and healthy individuals","volume":"17","author":"Hagemeier","year":"2018","journal-title":"Neuroimage Clin"},{"key":"10.1016\/j.autrev.2025.103741_bb0140","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/bpa.12643","article-title":"Iron related changes in MS lesions and their validity to characterize MS lesion types and dynamics with ultra-high field magnetic resonance imaging","volume":"28","author":"Hametner","year":"2018","journal-title":"Brain Pathol"},{"key":"10.1016\/j.autrev.2025.103741_bb0145","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/B978-0-12-410502-7.00009-0","article-title":"The neuropathology of neurodegeneration with brain iron accumulation","volume":"110","author":"Kruer","year":"2013","journal-title":"Int Rev Neurobiol"},{"key":"10.1016\/j.autrev.2025.103741_bb0150","article-title":"Iron rims as an imaging biomarker in MS: a systematic mapping review","volume":"10","author":"AlTokhis","year":"2020","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.autrev.2025.103741_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0057573","article-title":"Iron is a sensitive biomarker for inflammation in multiple sclerosis lesions","volume":"8","author":"Mehta","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.autrev.2025.103741_bb0160","doi-asserted-by":"crossref","first-page":"94","DOI":"10.12688\/wellcomeopenres.17731.1","article-title":"Rationale and design of the brain magnetic resonance imaging protocol for FutureMS: a longitudinal multi-centre study of newly diagnosed patients with relapsing-remitting multiple sclerosis in Scotland","volume":"7","author":"Meijboom","year":"2022","journal-title":"Wellcome Open Res"},{"key":"10.1016\/j.autrev.2025.103741_bb0165","doi-asserted-by":"crossref","first-page":"4447","DOI":"10.1007\/s00330-018-5461-8","article-title":"Optic radiations are thinner and show signs of iron deposition in patients with long-standing remitting-relapsing multiple sclerosis: an enhanced T(2)(*)-weighted angiography imaging study","volume":"28","author":"Zeng","year":"2018","journal-title":"Eur Radiol"},{"key":"10.1016\/j.autrev.2025.103741_bb0170","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s11538-023-01181-0","article-title":"Could mathematics be the key to unlocking the mysteries of multiple sclerosis?","volume":"85","author":"Weatherley","year":"2023","journal-title":"Bull Math Biol"},{"key":"10.1016\/j.autrev.2025.103741_bb0175","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000065702","article-title":"A morphological study of the developmentally regulated transport of iron into the brain","volume":"24","author":"Moos","year":"2002","journal-title":"Dev Neurosci"},{"key":"10.1016\/j.autrev.2025.103741_bb0180","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3389\/fneur.2017.00234","article-title":"Primary progressive multiple sclerosis: putting together the puzzle","volume":"8","author":"Abdelhak","year":"2017","journal-title":"Front Neurol"},{"key":"10.1016\/j.autrev.2025.103741_bb0185","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.mehy.2008.02.009","article-title":"Hypothetical molecular mechanisms by which local iron overload facilitates the development of venous leg ulcers and multiple sclerosis lesions","volume":"71","author":"Simka","year":"2008","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.autrev.2025.103741_bb0190","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1471-2350-13-70","article-title":"Polymorphisms in the genes coding for iron binding and transporting proteins are associated with disability, severity, and early progression in multiple sclerosis","volume":"13","author":"Gemmati","year":"2012","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.autrev.2025.103741_bb0195","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.3109\/10715762.2014.955484","article-title":"Changes in skeletal muscle iron metabolism outpace amyotrophic lateral sclerosis onset in transgenic rats bearing the G93A hmSOD1 gene mutation","volume":"48","author":"Halon","year":"2014","journal-title":"Free Radic Res"},{"key":"10.1016\/j.autrev.2025.103741_bb0200","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0022-510X(99)00077-5","article-title":"Distribution of transferrin and ferritin binding in normal and multiple sclerotic human brains","volume":"165","author":"Hulet","year":"1999","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.autrev.2025.103741_bb0205","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/ana.23974","article-title":"Iron and neurodegeneration in the multiple sclerosis brain","volume":"74","author":"Hametner","year":"2013","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2025.103741_bb0210","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.nic.2016.12.003","article-title":"Iron mapping in multiple sclerosis","volume":"27","author":"Ropele","year":"2017","journal-title":"Neuroimaging Clin N Am"},{"key":"10.1016\/j.autrev.2025.103741_bb0215","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1038\/s41467-024-46441-2","article-title":"Rab4A-directed endosome traffic shapes pro-inflammatory mitochondrial metabolism in T cells via mitophagy, CD98 expression, and kynurenine-sensitive mTOR activation","volume":"15","author":"Huang","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.autrev.2025.103741_bb0220","doi-asserted-by":"crossref","first-page":"709","DOI":"10.5604\/17322693.1208036","article-title":"Misregulation of iron homeostasis in amyotrophic lateral sclerosis","volume":"70","author":"Gajowiak","year":"2016","journal-title":"Postepy Hig Med Dosw (Online)"},{"key":"10.1016\/j.autrev.2025.103741_bb0225","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2025.103741_bb0230","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.2174\/0929867327999200917150652","article-title":"Biomarkers of senescence during aging as possible warnings to use preventive measures","volume":"28","author":"Gasmi","year":"2021","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.autrev.2025.103741_bb0235","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1186\/s12974-019-1674-2","article-title":"Molecular biomarkers in multiple sclerosis","volume":"16","author":"Ziemssen","year":"2019","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.autrev.2025.103741_bb0240","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12987-020-00190-8","article-title":"Evidence for communication of peripheral iron status to cerebrospinal fluid: clinical implications for therapeutic strategy","volume":"17","author":"Connor","year":"2020","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.autrev.2025.103741_bb0245","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/ana.410130302","article-title":"New diagnostic criteria for multiple sclerosis: guidelines for research protocols","volume":"13","author":"Poser","year":"1983","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2025.103741_bb0250","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/01.rmr.0000245461.90406.ad","article-title":"Role of iron in neurodegenerative disorders","volume":"17","author":"Berg","year":"2006","journal-title":"Top Magn Reson Imaging"},{"key":"10.1016\/j.autrev.2025.103741_bb0255","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1212\/01.wnl.0000259403.31527.ef","article-title":"Differential diagnosis and evaluation in pediatric multiple sclerosis","volume":"68","author":"Hahn","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2025.103741_bb0260","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1177\/1352458513484547","article-title":"International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions","volume":"19","author":"Krupp","year":"2013","journal-title":"Mult Scler"},{"key":"10.1016\/j.autrev.2025.103741_bb0265","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1177\/1352458508096878","article-title":"Differential diagnosis of suspected multiple sclerosis: a consensus approach","volume":"14","author":"Miller","year":"2008","journal-title":"Mult Scler"},{"key":"10.1016\/j.autrev.2025.103741_bb0270","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1471-2202-12-60","article-title":"Iron deposition and inflammation in multiple sclerosis. Which one comes first?","volume":"12","author":"Zivadinov","year":"2011","journal-title":"BMC Neurosci"},{"key":"10.1016\/j.autrev.2025.103741_bb0275","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1376838","article-title":"Iron metabolism disorder and multiple sclerosis: a comprehensive analysis","volume":"15","author":"Tang","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2025.103741_bb0280","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1212\/01.wnl.0000259421.40556.76","article-title":"Challenges in the classification of pediatric multiple sclerosis and future directions","volume":"68","author":"Belman","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2025.103741_bb0285","article-title":"Identifying the white matter pathways involved in multiple sclerosis-related tremor using diffusion tensor imaging","volume":"9","author":"Bayoumi","year":"2023","journal-title":"Mult Scler J Exp Transl Clin"},{"key":"10.1016\/j.autrev.2025.103741_bb0290","doi-asserted-by":"crossref","DOI":"10.1002\/nbm.4847","article-title":"Quantitative magnetic resonance imaging biomarkers for cortical pathology in multiple sclerosis at 7 T","volume":"36","author":"Straub","year":"2023","journal-title":"NMR Biomed"},{"key":"10.1016\/j.autrev.2025.103741_bb0295","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1177\/02841851221143050","article-title":"Automatic detection of active and inactive multiple sclerosis plaques using the Bayesian approach in susceptibility-weighted imaging","volume":"64","author":"Afkandeh","year":"2023","journal-title":"Acta Radiol"},{"key":"10.1016\/j.autrev.2025.103741_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.104968","article-title":"Reliability of paramagnetic rim lesion classification on quantitative susceptibility mapping (QSM) in people with multiple sclerosis: single-site experience and systematic review","volume":"79","author":"Reeves","year":"2023","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.autrev.2025.103741_bb0305","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1002\/mrm.26780","article-title":"Assessment of ferritin content in multiple sclerosis brains using temperature-induced R*(2) changes","volume":"79","author":"Birkl","year":"2018","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.autrev.2025.103741_bb0310","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/nbm.922","article-title":"High-field magnetic resonance imaging of brain iron: birth of a biomarker?","volume":"17","author":"Schenck","year":"2004","journal-title":"NMR Biomed"},{"key":"10.1016\/j.autrev.2025.103741_bb0315","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1295904","article-title":"Application value of plasma Neurofilament light combined with magnetic resonance imaging to comprehensively evaluate multiple sclerosis activity and status","volume":"14","author":"Mi","year":"2023","journal-title":"Front Neurol"},{"key":"10.1016\/j.autrev.2025.103741_bb0320","doi-asserted-by":"crossref","first-page":"W353","DOI":"10.2214\/AJR.12.9522","article-title":"Sclerosing angiomatoid nodular transformation of the spleen: CT and MRI features with pathologic correlation","volume":"200","author":"Lewis","year":"2013","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.autrev.2025.103741_bb0325","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1023\/A:1006948027674","article-title":"Transferrin and transferrin receptor function in brain barrier systems","volume":"20","author":"Moos","year":"2000","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.autrev.2025.103741_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2023.120816","article-title":"Magnetic resonance imaging detection of deep gray matter iron deposition in multiple sclerosis: a systematic review","volume":"453","author":"De Lury","year":"2023","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.autrev.2025.103741_bb0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2020.117285","article-title":"Ex vivo MR microscopy of a human brain with multiple sclerosis: visualizing individual cells in tissue using intrinsic iron","volume":"223","author":"Nair","year":"2020","journal-title":"Neuroimage"},{"key":"10.1016\/j.autrev.2025.103741_bb0340","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1007\/s10571-018-0578-5","article-title":"Cuprizone administration alters the iron metabolism in the mouse model of multiple sclerosis","volume":"38","author":"Varga","year":"2018","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.autrev.2025.103741_bb0345","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/14737175.2024.2304116","article-title":"An update on the role of magnetic resonance imaging in predicting and monitoring multiple sclerosis progression","volume":"24","author":"Ananthavarathan","year":"2024","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.autrev.2025.103741_bb0350","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jns.2011.01.003","article-title":"Patterns of levels of biological metals in CSF differ among neurodegenerative diseases","volume":"303","author":"Hozumi","year":"2011","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.autrev.2025.103741_bb0355","first-page":"1491","article-title":"Investigation of apparent diffusion coefficient and diffusion tensor anisotrophy in acute and chronic multiple sclerosis lesions","volume":"20","author":"Tievsky","year":"1999","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.autrev.2025.103741_bb0360","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1148\/radiol.2223010311","article-title":"Multiple sclerosis: diffusion tensor MR imaging for evaluation of normal-appearing white matter","volume":"222","author":"Guo","year":"2002","journal-title":"Radiology"},{"key":"10.1016\/j.autrev.2025.103741_bb0365","doi-asserted-by":"crossref","first-page":"5467","DOI":"10.1038\/s41467-023-40999-z","article-title":"Non-invasive assessment of normal and impaired iron homeostasis in the brain","volume":"14","author":"Filo","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.autrev.2025.103741_bb0370","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1136\/jnnp-2019-322042","article-title":"Brain iron deposition is linked with cognitive severity in Parkinson's disease","volume":"91","author":"Thomas","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.autrev.2025.103741_bb0375","doi-asserted-by":"crossref","first-page":"1468S","DOI":"10.1093\/jn\/133.5.1468S","article-title":"Iron deficiency alters brain development and functioning","volume":"133","author":"Beard","year":"2003","journal-title":"J Nutr"},{"key":"10.1016\/j.autrev.2025.103741_bb0380","doi-asserted-by":"crossref","first-page":"S560","DOI":"10.1177\/15648265070284S409","article-title":"Iron deficiency and child development","volume":"28","author":"Lozoff","year":"2007","journal-title":"Food Nutr Bull"},{"key":"10.1016\/j.autrev.2025.103741_bb0385","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.toxrep.2022.08.008","article-title":"Iron deficiency and cognitive impairment in children with low blood lead levels","volume":"9","author":"Maidoumi","year":"2022","journal-title":"Toxicol Rep"},{"key":"10.1016\/j.autrev.2025.103741_bb0390","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3174\/ajnr.A3998","article-title":"Iron and volume in the deep gray matter: association with cognitive impairment in multiple sclerosis","volume":"36","author":"Modica","year":"2015","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.autrev.2025.103741_bb0395","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1191\/135248506ms1301oa","article-title":"Cognitive impairment is associated with subcortical magnetic resonance imaging grey matter T2 hypointensity in multiple sclerosis","volume":"12","author":"Brass","year":"2006","journal-title":"Mult Scler"},{"key":"10.1016\/j.autrev.2025.103741_bb0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2023.110903","article-title":"Changes in iron load in specific brain areas lead to neurodegenerative diseases of the central nervous system","volume":"129","author":"Wang","year":"2024","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.autrev.2025.103741_bb0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.104740","article-title":"Enlarged choroid plexus related to iron rim lesions and deep gray matter atrophy in relapsing-remitting multiple sclerosis","volume":"75","author":"Wang","year":"2023","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.autrev.2025.103741_bb0410","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1177\/13524585231155639","article-title":"Cerebrospinal fluid-related tissue damage in multiple sclerosis patients with iron rim lesions","volume":"29","author":"Wittayer","year":"2023","journal-title":"Mult Scler"},{"key":"10.1016\/j.autrev.2025.103741_bb0415","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.103967","article-title":"Spatial distribution of multiple sclerosis iron rim lesions and their impact on disability","volume":"64","author":"Wittayer","year":"2022","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.autrev.2025.103741_bb0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.105379","article-title":"Multi-modal neuroimaging signatures predict cognitive decline in multiple sclerosis: a 5-year longitudinal study","volume":"81","author":"Al-Iedani","year":"2024","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.autrev.2025.103741_bb0425","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/13854040903266910","article-title":"Validity of the California verbal learning test-II in multiple sclerosis","volume":"24","author":"Stegen","year":"2010","journal-title":"Clin Neuropsychol"},{"key":"10.1016\/j.autrev.2025.103741_bb0430","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/arclin\/acac059","article-title":"Trail making test could predict impairment in cognitive domains in patients with multiple sclerosis: a study of diagnostic accuracy","volume":"38","author":"Kabiri","year":"2023","journal-title":"Arch Clin Neuropsychol"},{"key":"10.1016\/j.autrev.2025.103741_bb0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2023.108074","article-title":"Transcranial sonography in neurodegeneration with brain iron accumulation disorders","volume":"236","author":"Habibi","year":"2024","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.autrev.2025.103741_bb0440","article-title":"Brain Iron homeostasis and mental disorders","volume":"12","author":"Wu","year":"2023","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.autrev.2025.103741_bb0445","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.3348\/kjr.2023.0490","article-title":"Cortical iron accumulation as an imaging marker for neurodegeneration in clinical cognitive impairment spectrum: a quantitative susceptibility mapping study","volume":"24","author":"Kim","year":"2023","journal-title":"Korean J Radiol"},{"key":"10.1016\/j.autrev.2025.103741_bb0450","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1007\/s10571-023-01332-w","article-title":"Autolysis affects the Iron cargo of ferritins in neurons and glial cells at different rates in the human brain","volume":"43","author":"Sunkara","year":"2023","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.autrev.2025.103741_bb0455","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200213","article-title":"Single-cell multi-omics map of cell type-specific mechanistic drivers of multiple sclerosis lesions","volume":"11","author":"Elkjaer","year":"2024","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.autrev.2025.103741_bb0460","doi-asserted-by":"crossref","DOI":"10.1177\/1759091415587502","article-title":"Semaphorin4A is cytotoxic to oligodendrocytes and is elevated in microglia and multiple sclerosis","volume":"7","author":"Leitner","year":"2015","journal-title":"ASN Neuro"},{"key":"10.1016\/j.autrev.2025.103741_bb0465","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/nature01037","article-title":"Class IV semaphorin Sema4A enhances T-cell activation and interacts with Tim-2","volume":"419","author":"Kumanogoh","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2025.103741_bb0470","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.neuroscience.2016.05.025","article-title":"Iron-induced neuronal damage in a rat model of post-traumatic stress disorder","volume":"330","author":"Zhao","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.autrev.2025.103741_bb0475","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.1016\/j.neuron.2022.06.023","article-title":"Microglia in multiple sclerosis: protectors turn destroyers","volume":"110","author":"Yong","year":"2022","journal-title":"Neuron"},{"key":"10.1016\/j.autrev.2025.103741_bb0480","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1159\/000065692","article-title":"Role of porphyrin sequestration in the biogenesis of iron-laden astrocytic inclusions in primary culture","volume":"24","author":"Schipper","year":"2002","journal-title":"Dev Neurosci"},{"key":"10.1016\/j.autrev.2025.103741_bb0485","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3389\/fncel.2016.00119","article-title":"Astrocytes in oligodendrocyte lineage development and White matter pathology","volume":"10","author":"Li","year":"2016","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.autrev.2025.103741_bb0490","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40035-020-00221-2","article-title":"Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes","volume":"9","author":"Kwon","year":"2020","journal-title":"Transl Neurodegener"},{"key":"10.1016\/j.autrev.2025.103741_bb0495","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2023.103524","article-title":"Metabolic insights into Iron deposition in relapsing-remitting multiple sclerosis via 7 T magnetic resonance spectroscopic imaging","volume":"40","author":"Lipka","year":"2023","journal-title":"Neuroimage Clin"},{"key":"10.1016\/j.autrev.2025.103741_bb0500","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1177\/13524585221114750","article-title":"Longitudinal clinical study of patients with iron rim lesions in multiple sclerosis","volume":"28","author":"Altokhis","year":"2022","journal-title":"Mult Scler"},{"key":"10.1016\/j.autrev.2025.103741_bb0505","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1038\/s41418-023-01195-0","article-title":"Ferroptosis contributes to multiple sclerosis and its pharmacological targeting suppresses experimental disease progression","volume":"30","author":"Van San","year":"2023","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.autrev.2025.103741_bb0510","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000510083","article-title":"Ferroptosis is regulated by mitochondria in neurodegenerative diseases","volume":"20","author":"Zhou","year":"2020","journal-title":"Neurodegener Dis"},{"key":"10.1016\/j.autrev.2025.103741_bb0515","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2024.103640","article-title":"Targeting ferroptosis in autoimmune diseases: mechanisms and therapeutic prospects","volume":"23","author":"Zheng","year":"2024","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2025.103741_bb0520","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00401-014-1263-5","article-title":"Oxidative tissue injury in multiple sclerosis is only partly reflected in experimental disease models","volume":"128","author":"Schuh","year":"2014","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.autrev.2025.103741_bb0525","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/bs.apcsb.2020.09.002","article-title":"The role of transferrins and iron-related proteins in brain iron transport: applications to neurological diseases","volume":"123","author":"Campos-Escamilla","year":"2021","journal-title":"Adv Protein Chem Struct Biol"},{"key":"10.1016\/j.autrev.2025.103741_bb0530","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1007\/s00330-021-08233-w","article-title":"Association of iron rim lesions with brain and cervical cord volume in relapsing multiple sclerosis","volume":"32","author":"Weber","year":"2022","journal-title":"Eur Radiol"},{"key":"10.1016\/j.autrev.2025.103741_bb0535","article-title":"Ferroptosis mechanisms involved in hippocampal-related diseases","volume":"22","author":"Wang","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.autrev.2025.103741_bb0540","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/jnc.15831","article-title":"Ferroptosis and central nervous system demyelinating diseases","volume":"165","author":"Qin","year":"2023","journal-title":"J Neurochem"},{"key":"10.1016\/j.autrev.2025.103741_bb0545","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.105020","article-title":"Dysregulation of humoral immunity, iron homeostasis, and lipid metabolism is associated with multiple sclerosis progression","volume":"79","author":"Wang","year":"2023","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.autrev.2025.103741_bb0550","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1137635","article-title":"The role of iron metabolism in the pathogenesis and treatment of multiple sclerosis","volume":"14","author":"Duarte-Silva","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2025.103741_bb0555","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e24786","article-title":"Role of ferroptosis pathways in neuroinflammation and neurological disorders: from pathogenesis to treatment","volume":"10","author":"Mohan","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.autrev.2025.103741_bb0560","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2022.119503","article-title":"Susceptibility networks reveal independent patterns of brain iron abnormalities in multiple sclerosis","volume":"261","author":"Reeves","year":"2022","journal-title":"Neuroimage"},{"key":"10.1016\/j.autrev.2025.103741_bb0565","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.904152","article-title":"Mechanisms of ferroptosis and emerging links to the pathology of neurodegenerative diseases","volume":"14","author":"Sun","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.autrev.2025.103741_bb0570","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jtemb.2016.03.010","article-title":"Iron chelation in the treatment of neurodegenerative diseases","volume":"38","author":"Dusek","year":"2016","journal-title":"J Trace Elem Med Biol"},{"key":"10.1016\/j.autrev.2025.103741_bb0575","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00702-010-0518-0","article-title":"Iron chelation and neuroprotection in neurodegenerative diseases","volume":"118","author":"Li","year":"2011","journal-title":"J Neural Transm (Vienna)"},{"key":"10.1016\/j.autrev.2025.103741_bb0580","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jtemb.2016.05.010","article-title":"Chemical features of in use and in progress chelators for iron overload","volume":"38","author":"Nurchi","year":"2016","journal-title":"J Trace Elem Med Biol"},{"key":"10.1016\/j.autrev.2025.103741_bb0585","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2022.114113","article-title":"Myelinated axons are the primary target of hemin-mediated oxidative damage in a model of the central nervous system","volume":"354","author":"Baldacchino","year":"2022","journal-title":"Exp Neurol"},{"key":"10.1016\/j.autrev.2025.103741_bb0590","article-title":"Role of Iron in aging related diseases","volume":"11","author":"Chen","year":"2022","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.autrev.2025.103741_bb0595","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1080\/19390211.2021.1922567","article-title":"Lactoferrin for mental health: neuro-redox regulation and neuroprotective effects across the blood-brain barrier with special reference to neuro-COVID-19","volume":"20","author":"Naidu","year":"2023","journal-title":"J Diet Suppl"},{"key":"10.1016\/j.autrev.2025.103741_bb0600","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ccr.2014.04.023","article-title":"Kill or cure: misuse of chelation therapy for human diseases","volume":"284","author":"Crisponi","year":"2015","journal-title":"Coord Chem Rev"},{"key":"10.1016\/j.autrev.2025.103741_bb0605","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1007\/s40263-019-00668-6","article-title":"Targeting iron dyshomeostasis for treatment of neurodegenerative disorders","volume":"33","author":"Bergsland","year":"2019","journal-title":"CNS Drugs"},{"key":"10.1016\/j.autrev.2025.103741_bb0610","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/WNR.0000000000000804","article-title":"Serum iron concentration is associated with subcortical deep gray matter iron levels in multiple sclerosis patients","volume":"28","author":"Bergsland","year":"2017","journal-title":"Neuroreport"},{"key":"10.1016\/j.autrev.2025.103741_bb0615","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.102035","article-title":"Research on ferroptosis as a therapeutic target for the treatment of neurodegenerative diseases","volume":"91","author":"Wang","year":"2023","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.autrev.2025.103741_bb0620","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5662\/wjm.v6.i1.1","article-title":"New developments and controversies in iron metabolism and iron chelation therapy","volume":"6","author":"Kontoghiorghe","year":"2016","journal-title":"World J Methodol"},{"key":"10.1016\/j.autrev.2025.103741_bb0625","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s00702-019-02138-1","article-title":"Conservative iron chelation for neurodegenerative diseases such as Parkinson's disease and amyotrophic lateral sclerosis","volume":"127","author":"Devos","year":"2020","journal-title":"J Neural Transm (Vienna)"},{"key":"10.1016\/j.autrev.2025.103741_bb0630","article-title":"MR susceptibility separation for quantifying lesion paramagnetic and diamagnetic evolution in relapsing-remitting multiple sclerosis","author":"Zhu","year":"2024","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.autrev.2025.103741_bb0635","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1111\/ene.15834","article-title":"Longitudinal stability of progression-related microglial activity during teriflunomide treatment in patients with multiple sclerosis","volume":"30","author":"Lehto","year":"2023","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.autrev.2025.103741_bb0640","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.104970","article-title":"Disease modifying treatment for pediatric onset multiple sclerosis: ethical considerations and strategies to navigate parental refusal","volume":"79","author":"Wilson","year":"2023","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.autrev.2025.103741_bb0645","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.4103\/1673-5374.213542","article-title":"Metabolic pathways as possible therapeutic targets for progressive multiple sclerosis","volume":"12","author":"Heidker","year":"2017","journal-title":"Neural Regen Res"},{"key":"10.1016\/j.autrev.2025.103741_bb0650","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2021.135627","article-title":"Mini-review: is iron-mediated cell death (ferroptosis) an identical factor contributing to the pathogenesis of some neurodegenerative diseases?","volume":"745","author":"Viktorinova","year":"2021","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.autrev.2025.103741_bb0655","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainresbull.2024.110878","article-title":"Deferoxamine reduces endothelial ferroptosis and protects cerebrovascular function after experimental traumatic brain injury","volume":"207","author":"Liang","year":"2024","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.autrev.2025.103741_bb0660","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2023.148383","article-title":"Deferoxamine ameliorates neurological dysfunction by inhibiting ferroptosis and neuroinflammation after traumatic brain injury","volume":"1812","author":"Jia","year":"2023","journal-title":"Brain Res"},{"key":"10.1016\/j.autrev.2025.103741_bb0665","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/s41582-019-0235-8","article-title":"Drug reduces excess iron in ultra-rare neurodegenerative disease","volume":"15","author":"Lempri\u00e8re","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.autrev.2025.103741_bb0670","doi-asserted-by":"crossref","first-page":"4418","DOI":"10.1021\/mp4002014","article-title":"Enhanced brain delivery of deferasirox-lactoferrin conjugates for iron chelation therapy in neurodegenerative disorders: in vitro and in vivo studies","volume":"10","author":"Kamalinia","year":"2013","journal-title":"Mol Pharm"},{"key":"10.1016\/j.autrev.2025.103741_bb0675","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2174\/0929867325666180904104318","article-title":"Therapeutic macromolecular iron chelators","volume":"26","author":"Bulbake","year":"2019","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.autrev.2025.103741_bb0680","doi-asserted-by":"crossref","first-page":"6517","DOI":"10.1039\/C6DT00129G","article-title":"Hydroxypyridinones with enhanced iron chelating properties. Synthesis, characterization and in vivo tests of 5-hydroxy-2-(hydroxymethyl)pyridine-4(1H)-one","volume":"45","author":"Lachowicz","year":"2016","journal-title":"Dalton Trans"},{"key":"10.1016\/j.autrev.2025.103741_bb0685","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jinorgbio.2014.09.002","article-title":"A new bis-3-hydroxy-4-pyrone as a potential therapeutic iron chelating agent. Effect of connecting and side chains on the complex structures and metal ion selectivity","volume":"141","author":"Nurchi","year":"2014","journal-title":"J Inorg Biochem"},{"key":"10.1016\/j.autrev.2025.103741_bb0690","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jinorgbio.2019.01.012","article-title":"A new tripodal kojic acid derivative for iron sequestration: synthesis, protonation, complex formation studies with Fe(3+), Al(3+), Cu(2+) and Zn(2+), and in vivo bioassays","volume":"193","author":"Nurchi","year":"2019","journal-title":"J Inorg Biochem"},{"key":"10.1016\/j.autrev.2025.103741_bb0695","author":"Multiple Sclerosis Society"},{"key":"10.1016\/j.autrev.2025.103741_bb0700","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24119637","article-title":"Iron and Ferroptosis more than a suspect: beyond the most common mechanisms of neurodegeneration for new therapeutic approaches to cognitive decline and dementia","volume":"24","author":"Cerasuolo","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.autrev.2025.103741_bb0705","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.amjmed.2020.05.049","article-title":"Treatment of multiple sclerosis: a review","volume":"133","author":"Hauser","year":"2020","journal-title":"Am J Med"},{"key":"10.1016\/j.autrev.2025.103741_bb0710","article-title":"Comparative effectiveness of high-efficacy and moderate efficacy disease-modifying agents in reducing the annualized relapse rates among multiple sclerosis patients in the United States","volume":"190","author":"Li","year":"2024","journal-title":"Prev Med"},{"key":"10.1016\/j.autrev.2025.103741_bb0715","article-title":"Determinants of long-term paramagnetic rim lesion evolution in people with multiple sclerosis","author":"Reeves","year":"2024","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.autrev.2025.103741_bb0720","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2217\/nmt-2021-0058","article-title":"Updates and advances in multiple sclerosis neurotherapeutics","volume":"13","author":"Amin","year":"2023","journal-title":"Neurodegener Dis Manag"},{"key":"10.1016\/j.autrev.2025.103741_bb0725","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2407974121","article-title":"Targeting the muscarinic M1 receptor with a selective, brain-penetrant antagonist to promote remyelination in multiple sclerosis","volume":"121","author":"Poon","year":"2024","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.autrev.2025.103741_bb0730","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2024.110398","article-title":"Comparative analysis of the B cell receptor repertoire during relapse and remission in patients with multiple sclerosis","volume":"269","author":"Perez-Saldivar","year":"2024","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2025.103741_bb0735","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2024.123303","article-title":"Multi-omic characterization of the effects of ocrelizumab in patients with relapsing-remitting multiple sclerosis","volume":"467","author":"Kornilov","year":"2024","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.autrev.2025.103741_bb0740","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/1028415X.2024.2425649","article-title":"Effects of resveratrol supplementation on inflammatory markers, fatigue scale, fasting blood sugar and lipid profile in relapsing-remitting multiple sclerosis patients: a double-blind, randomized placebo-controlled trial","author":"Keramatzadeh","year":"2024","journal-title":"Nutr Neurosci"},{"key":"10.1016\/j.autrev.2025.103741_bb0745","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1186\/s12974-024-03295-1","article-title":"IL-37 suppresses CNS autoimmunity by increasing the frequency of Treg cells and reducing CD4 + T cell-derived IL-10 production","volume":"21","author":"Yazdani","year":"2024","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.autrev.2025.103741_bb0750","doi-asserted-by":"crossref","first-page":"8775","DOI":"10.2147\/JIR.S476110","article-title":"Hyperresponsiveness of corticoid-resistant Th17\/Tc-17 cells to TLR-2 and TLR-4 ligands is a feature of multiple sclerosis patients at higher risk of therapy failure","volume":"17","author":"Hygino","year":"2024","journal-title":"J Inflamm Res"},{"key":"10.1016\/j.autrev.2025.103741_bb0755","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.freeradbiomed.2018.09.033","article-title":"Striking while the iron is hot: iron metabolism and ferroptosis in neurodegeneration","volume":"133","author":"Masaldan","year":"2019","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.autrev.2025.103741_bb0760","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.brainres.2003.10.066","article-title":"Expression of the iron transporter ferroportin in synaptic vesicles and the blood-brain barrier","volume":"1001","author":"Wu","year":"2004","journal-title":"Brain Res"},{"key":"10.1016\/j.autrev.2025.103741_bb0765","article-title":"Broadening horizons: ferroptosis as a new target for traumatic brain injury, burns","volume":"12","author":"Wei","year":"2024","journal-title":"Trauma"},{"key":"10.1016\/j.autrev.2025.103741_bb0770","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12987-023-00464-x","article-title":"Relationship between brain iron dynamics and blood-brain barrier function during childhood: a quantitative magnetic resonance imaging study","volume":"20","author":"Uchida","year":"2023","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.autrev.2025.103741_bb0775","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1159\/000065699","article-title":"Mechanism and developmental changes in iron transport across the blood-brain barrier","volume":"24","author":"Morgan","year":"2002","journal-title":"Dev Neurosci"},{"key":"10.1016\/j.autrev.2025.103741_bb0780","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1111\/j.1471-4159.2007.04976.x","article-title":"Iron trafficking inside the brain","volume":"103","author":"Moos","year":"2007","journal-title":"J Neurochem"},{"key":"10.1016\/j.autrev.2025.103741_bb0785","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.3389\/fimmu.2019.01564","article-title":"Immunological aspects of approved MS therapeutics","volume":"10","author":"Rommer","year":"2019","journal-title":"Front Immunol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997225000011?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997225000011?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T13:37:07Z","timestamp":1740922627000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997225000011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":157,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S1568997225000011"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2025.103741","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cerebral iron accumulation in multiple sclerosis: Pathophysiology and therapeutic implications","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2025.103741","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103741"}}